Location: Home
  • search
  • go
  • Relate News
  • 3/12/2025Harbour BioMed Launches Élancé Therapeutics to Advance Next-Generati...
  • 3/12/2025Novartis' Cosentyx Receives Fifth Indication Approval in China for Hid...
  • 3/12/2025NewDEL Biotech Completes Series A+ Financing Led by XtalPi to Accelera...
  • 3/11/2025TYK Medicines Announces Pivotal Phase II Trial of TY-9591 Vs Osimertin...
  • 3/11/2025InnoCare Presents Promising Phase II Data on ICP-488 for Psoriasis
  • 3/11/2025RockRoc Secures Pre-A+ Financing to Advance Macrophage-Based Cancer Th...
  • 3/11/2025Juvensis Secures Over CNY 100M in Pre-A Financing to Advance Gene The...
  • 3/11/2025Pfizer's Elrexfio Receives Conditional Approval in China for Advanced ...
  • 3/11/2025MindRank's AI-Designed Dual Kinase Inhibitor MRANK-106 Receives FDA IN...
  • 3/11/2025Chinese Scientists Develop Potential Vaccine to Prevent Stroke and Hea...
  • 3/11/2025Over 100 Chinese Pharma Firms Report Losses as 319 Firms Release 2024 ...
  • 3/10/2025China to Expand Mental Health Services Nationwide: Official
  • 3/10/2025China's Life Expectancy Reaches 79 Years in 2024, Surpassing Health Pl...
  • 3/10/2025China Expands BMI Coverage to Over 90% of Village Clinics
  • 3/10/2025China Approves AbbVie's Skyrizi for Active Crohn's Disease Treatment
  • 3/10/2025Nona Bio Launches AI-Assisted Drug Discovery Platform Hu-mAtrIx
  • 3/10/2025The Bright Future Amidst Challenges: An Outlook on China's Pharma Econ...
  • 3/10/2025China Biopharma Tracker – February 2025 (PharmaDJ)
  • 3/7/2025CStone Submits Clinical Trial Application in Australia for CS5001 in D...
  • 3/7/2025Enhua Pharma Acquires 10.4% Stake in NeuroThree with $3.5M Investment...
  • 3/7/2025Innovent Launches Phase 2 Trial of IBI362 for Heart Failure Patients w...
  • 3/7/2025Recent Executive Moves
  • 3/6/2025Bayer Expands Innovation in China with New E-Town Center
  • 3/6/2025Nhwa Pharma Acquires Stake in Neuro3 to Expand CNS Drug Pipeline  
  • 3/6/2025AI, Biomanufacturing, and Six Takeaways from China’s Government Work ...
  • 3/5/2025CStone Announces First Patient Dosed in Global Trial of Trispecific An...
  • 3/5/2025China to Adjust Centralized Drug Procurement Policies
  • 3/4/2025Raziel and Fosun's JuveStar Launch Phase 3 Trial in China for RZL-012
  • 3/4/2025Amoytop's Strategic Acquisition of Skyline Assets Marks Expansion into...
  • 3/4/2025Insilico and Tenacia Announce Research Collaboration for CNS Drug Disc...
  • Page:21/775 Total number of articles:23233: [First][<<] [19] [20] [21] [22] [23] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group